Colonial Trust Advisors’s Editas Medicine EDIT Stock Holding History

Colonial Trust Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$97	Hold	30	–	–	﹤0.01%	788
2026 Q1	$74	Hold	30	–	–	﹤0.01%	710
2025 Q4	$62	Hold	30	–	–	﹤0.01%	687
2025 Q3	$104	Hold	30	–	–	﹤0.01%	672
2025 Q2	$66	Hold	30	–	–	﹤0.01%	687
2025 Q1	$35	Hold	30	–	–	﹤0.01%	669
2024 Q4	$38	Hold	30	–	–	﹤0.01%	671
2024 Q3	$102	Hold	30	–	–	﹤0.01%	737
2024 Q2	$140	Hold	30	–	–	﹤0.01%	740
2024 Q1	$223	Hold	30	–	–	﹤0.01%	970
2023 Q4	$304	Hold	30	–	–	﹤0.01%	845
2023 Q3	$234	Hold	30	–	–	﹤0.01%	864
2023 Q2	$247	Hold	30	–	–	﹤0.01%	866
2023 Q1	$218	Hold	30	–	–	﹤0.01%	860
2022 Q4	$266	Buy	+30	New	+$329	﹤0.01%	858

Other funds holding EDIT

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Colonial Trust Advisors's EDIT Position: Q2 2026 in Review

Colonial Trust Advisors held its Editas Medicine (EDIT) position steady in Q2 2026 at 30 shares worth $97. The position accounts for ﹤0.01% of the portfolio, ranked #788.

Colonial Trust Advisors first reported a position in EDIT in Q4 2022 and has held it in 15 quarters since. The position peaked at $304 in Q4 2023. 216 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

Colonial Trust Advisors held 30 shares of Editas Medicine worth $97 as of Q2 2026.
Colonial Trust Advisors left its Editas Medicine share count unchanged in Q2 2026.
Editas Medicine made up ﹤0.01% of Colonial Trust Advisors's portfolio in Q2 2026, its #788 holding.
Colonial Trust Advisors first reported a position in Editas Medicine in Q4 2022 and has held it in 15 quarters since.
Colonial Trust Advisors's Editas Medicine position peaked at $304 in Q4 2023.
216 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Colonial Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.